Education
About Us
Working with TipRanks
Follow Us
Haleon PLC (GB:HLN)
LSE:HLN
Earnings Data
Report Date
Jul 31, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
9.1Last Year’s EPS
3.9Same Quarter Last Year
Moderate Buy
Based on 10 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 27, 2025
|% Change Since: -5.31%
|Next Earnings Date:Jul 31, 2025
Earnings Call Sentiment|Neutral
The earnings call highlighted strong performance in emerging markets and the Oral Health segment, driven by innovation and strategic investments. However, challenges such as a weak cold and flu season, disappointing Eroxon launch, and currency headwinds were notable concerns. Despite these issues, the company remains confident in its growth outlook and has committed to returning capital to shareholders.Company Guidance
During the call, Haleon provided guidance for 2025, indicating a projected growth of 4% to 6%, despite a slow start due to factors like a 15% decline in the cold and flu market and inventory adjustments. The company expressed confidence in its performance, highlighting that 71% of its business maintained or gained market share in 2024. Key growth drivers include strong momentum in emerging markets like India and China, robust performance in the Oral Health segment, and ongoing innovation across categories, such as Otrivin Nasal Mist and Centrum Silver. The company also mentioned a £500 million share buyback and maintained capacity for bolt-on M&A, despite ongoing currency headwinds of 1% to 2.5% on revenue and margin. Haleon's strategic focus remains on innovation, expanding market reach, and optimizing operational efficiency.Strong Performance in Emerging Markets
Significant momentum observed in emerging markets, especially in India and China, contributing to growth expectations for the second half of 2025.
Oral Health Segment Expansion
Successful performance in Oral Health with notable products like Clinical White, planned expansion into 12 more markets, and new launches such as clinical enamel repair in the US.
Innovation Driving Growth
Innovation is a key driver across all categories, with new products like Otrivin Nasal Mist and Centrum Essentials contributing to share gains and category growth.
Increased Investment in Growth
Continued focus on investing in growth with a 10.2% increase in A&P investment, indicating confidence in business fundamentals.
Capital Return to Shareholders
Announcement of a £500 million share buyback and increased dividend, reflecting strong cash flow confidence.
---
GB:HLN Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
GB:HLN Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 27, 2025 | 395.50p | 382.40p | -3.31% |
| Aug 01, 2024 | 347.73p | 356.08p | +2.40% |
| Feb 29, 2024 | 308.31p | 325.49p | +5.57% |
| Aug 02, 2023 | 322.28p | 314.12p | -2.53% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Haleon PLC (GB:HLN) report earnings?
Haleon PLC (GB:HLN) is schdueled to report earning on Jul 31, 2025, TBA Not Confirmed.
What is Haleon PLC (GB:HLN) earnings time?
Haleon PLC (GB:HLN) earnings time is at Jul 31, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is the P/E ratio of Haleon PLC stock?
The P/E ratio of Haleon PLC is N/A.
What is GB:HLN EPS forecast?
GB:HLN EPS forecast for the fiscal quarter 2025 (Q2) is 9.1.
---